Ondansetron is a selective 5-HT (serotonin type 3) receptor antagonist
Phase 3 Trial of Semaglutide in Metabolic DysfunctionAssociated Steatohepatitis, New England Journal of Medicine Consistent with previous trials, the semaglutide group also lost more body weight and had significant improvements in blood pressure, blood glucose, lipids, and inflammation compared to the placebo group
Semaglutide sodium is the salt form, which has a slightly higher molecular weight than semaglutide base
Recommended strategies include regular exercise, stress management techniques, avoiding smoking triggers, and seeking support from friends, family, or support groups
Yes, adding some changes to your lifestyle can help semaglutide work better for weight loss